drugset / Trial / NCT05139238

Postpartum Hypertension Study

NCT05139238

Phase 4 Terminated 2 enrolled Columbia University
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby.

Timeline

Start
2022-07-04
Primary completion
2025-08-21
Completion
2025-08-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator Labetalol Small molecule 80 mg Intravenous
Comparator Nifedipine Other / unclassified 20 mg Oral

Indications